47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,1 | 0,3 | 148,3 |
EBITDA | 0,1 | 0,1 | 0,3 | 145,1 |
Short time liabilities | 0,4 | 0,5 | 0,6 | 10,6 |
Equity capital | 0,3 | 0,3 | 0,5 | 50,8 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,3 | 161,4 |
Assets | 0,7 | 0,8 | 1 | 25,6 |
Net profit (loss) | 0,1 | 0,1 | 0,3 | 144,6 |
Cash | 0,2 | 0,2 | 0,2 | -3,1 |
Net income from sale | 3 | 3,8 | 5,3 | 39,2 |
Liabilities and provisions for liabilities | 0,4 | 0,5 | 0,6 | 10,6 |
Working assets | 0,7 | 0,8 | 1 | 19,9 |
Depreciation | 0 | 0 | 0 | -45 |
% | % | % | p.p. | |
Profitability of capital | 19,5 | 34,4 | 55,8 | 21,4 |
Equity capital to total assets | 40,3 | 37,4 | 44,8 | 7,4 |
Gross profit margin | 2,1 | 2,9 | 5,2 | 2,3 |
EBITDA Margin | 2 | 3 | 5,2 | 2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | 48 | 38 | -10 |
Current financial liquidity indicator | 1.675113558769226 | 1.5937198400497437 | 1.7265163660049438 | 0,1 |
Net dept to EBITDA | -3.721945285797119 | -1.94045889377594 | -0.7673175930976868 | 1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane